Major Ocular Abnormalities Among Hemodialysis Patients in Indonesia

Authors

  • Sauli Ari Widjaja 1. Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan. 2. Department of Ophthalmology, Faculty of Medicine Universitas Airlangga - Dr. Soetomo Hospital, Surabaya, East Java, Indonesia. http://orcid.org/0000-0002-7033-524X
  • Koichi Ono Department of Ophthalmology, Juntendo Tokyo Koto Geriatric Medical Center, Tokyo, Japan
  • Yoshimune Hiratsuka Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan
  • Ima Yustiarini Department of Ophthalmology, Faculty of Medicine Universitas Airlangga - Dr. Soetomo Hospital, Surabaya, East Java, Indonesia
  • Widodo Widodo Department of Internal Medicine, Faculty of Medicine Universitas Airlangga - Dr. Soetomo Hospital, Surabaya, East Java, Indonesia
  • Akira Murakami Department of Ophthalmology, Juntendo University Graduate School of Medicine, Tokyo, Japan

Keywords:

hemodialysis, ocular abnormality, ocular manifestation, chronic kidney disease, health-system

Abstract

Background: This study aimed to identify the major ocular abnormality findings (i.e., cataract and conjunctival and corneal calcification (CCC)) among hemodialysis (HD) patients and their risk factors. Methods: A single institute-based cross-sectional study in Indonesia. Demographic data, medical histories, and complete ocular examinations were collected. For two major ocular abnormalities found, a generalized estimating equation was incorporated in a logistic regression model to assess the relationship with their risk factors. Results: We analyzed 318 eyes (159 individuals), of which 54.7% male and 45.3% female. The mean age was 51.6±11.3 years. The mean HD period was 3.5±3.2 years. Hypertension and diabetes mellitus (DM) was found in 81.1% and 34.6%, respectively. The major ocular abnormalities found were cataract (206 eyes; 64.78% (95% CI 59.53-70.03)), followed by CCC (135 eyes; 42.45% (95 % CI 37.02-47.88)). In a multivariate model, higher education (odds ratio (OR) 0.17; 95% CI 0.04-0.74), hypertension (OR 0.15; 95% CI 0.03-0.79), DM (OR 10.49; 95% CI 1.57-70.06), Systolic Blood Pressure (SBP) 120-129 mmHg (OR 0.05; 95% CI 0.003-0.69), SBP >140 mmHg (OR 0.05; 95% CI 0.004-0.67), Diastolic Blood Pressure (DBP) 80-89 mmHg (OR 7.44; 95% CI 1.13-48.73), and DBP >90 mmHg (OR 48.47; 95% CI 3.4-692.03) showed significant association with cataract. Meanwhile, there was no significant association between CCC and any predictor. Conclusion: Cataract and CCC were found to be the major ocular abnormalities among HD patients in this study, with DM and higher DBP as the risk factors for cataract. This finding supports recommendations for integrated regular eye screening in HD patients.

References

Prasad N, Jha V. Hemodialysis in Asia. Kidney Dis. 2015;1:165–77.

Prodjosudjadi W, Suhardjono A. Indonesia: Treatment Development. Spring. 2009;19:33–6.

Wong CW, et al. Increased burden of vision impairment and eye diseases in persons with chronic kidney disease - A population-based study. E Bio Med. 2016;5:193–7.

Thulasidas M. Ocular evaluation in patients with chronic kidney disease - A hospital based study. Open Access J Ophthalmol. 2018;3.

Deva R, et al. Vision-threatening retinal abnormalities in chronic kidney disease stages 3 to 5. Clin J Am Soc Nephrol. 2011;6:1866–71.

Vrabec R, et al. Ocular findings in patients with chronic renal failure undergoing haemodialysis. Coll Antropol. 2005;29:95–8.

Farzan Kianersi ST, Shahin Fesharaki, Hamid Fesharaki M, et al. Ocular manifestations in hemodialysis patients: Importance of ophthalmic examination in prevention of ocular sequels. Int J Prev Med. 2019;10–20. doi:10.4103/ijpvm.IJPVM.

Mullaem G, Rosner MH. Ocular problems in the patient with end-stage renal disease. Semin Dial. 2012;25:403–7.

Hong YA, et al. The association of visual impairment with clinical outcomes in hemodialysis patients. Med. (United States). 2016;95:1–10.

Grunwald JE, et al. Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010;5:867–73.

Malleswari B. Eye findings in chronic renal failure patients undergoing hemodialysis. Int J Contemp Med Res. 2016;343:2393–915.

Hsiao CH, et al. Association of severity of conjunctival and corneal calcification with all-cause 1-year mortality in maintenance haemodialysis patients. Nephrol Dial Transplant. 2011;26:1016–23.

Mahmood N, Chowdhury SS. Retinopathy and neuropathy in patients with end stage renal disease on haemodialysis- a hospital based study. Anwer Khan Mod Med Coll J. 2015;6:14–9.

Basit I, et al. Frequency of diabetic retinopathy among dialysis patients and their awareness about the need for screening to prevent blindness. 2014;64:88–91.

Rim TH, Yoon CY, Park HW, Chung EJ. Association between starting hemodialysis for end-stage renal disease and incident cataract surgery: A 12-year nationwide cohort study. Investig Ophthalmol Vis Sci. 2016;57:1112–9.

Jonas JB, et al. Chronic kidney disease and eye diseases: The Beijing eye study. Ophthalmology. 2017;124:1566–9.

Aliu RO, Onua A, Adio AO, Awoyesuku E. Visual impairment among patients with chronic kidney disease undergoing haemodialysis in a tertiary health institution in Southern Nigeria. 2020.

Chiu E, Markowitz SN, Cook WL, Jassal SV. Visual impairment in elderly patients receiving long-term hemodialysis. Am J Kidney Dis. 2008;52:1131–8.

Porter R, Crombie AL. Corneal and conjunctival calcification in chronic renal failure. Br J Ophthalmol. 1973;57:339–43.

Kristina SA, Endarti D, Andayani TM, A. H. Cost of illness of hemodialysis in Indonesia: A survey from eight hospitals in Indonesia. Int J Pharm Res. 2021;13.

Létourneau I, Ouimet D, Dumont M, Pichette V, Leblanc M. Renal replacement in end-stage renal disease patients over 75 years old. Am J Nephrol. 2003;23:71–7.

Sladoje-Martinovic B, Mikolasevic I, Bubic I, Racki S, Orlic L. Survival of chronic hemodialysis patients over 80 years of age. Clin Interv Aging. 2014;9:689–96.

Lim JU, et al. Comparison of World Health Organization and Asia-Pacific body mass index classifications in COPD patients. 2017;2465–75.

Whelton PK, Carey RM, Aronow WS, et al. Guideline for the prevention, detection, evaluation, and management of high blood pressure in adults. J Am Coll Cardiol. 2017;23976:1–28.

Liu YT, et al. Association between chronic kidney disease and risk of cataract: A nationwide retrospective cohort study. Am J Nephrol. 2017;45:524–31.

Mack HG, Savige J. Chronic kidney disease and cataract: Seeing the light. Am J Nephrol. 2017;45: 522–3.

Wong CW, Wong TY, Cheng CY, Sabanayagam C. Kidney and eye diseases: Common risk factors, etiological mechanisms, and pathways. Kidney Int. 2014;85:1290–302.

Ye J, Lou LX, He JJ, Xu YF. Body mass index and risk of age-related cataract: A meta-analysis of prospective cohort studies. PLoS One. 2014;9.

Mansour D, El-Bayomi A, El-Azab A. Abnormal ocular findings in chronic renal failure patients on hemodialysis. Egypt J Hosp Med. 2018;72:5640–6.

Nusinovici S, Sabanayagam C, Teo BW, Tan GSW, Wong TY. Vision impairment in CKD patients: epidemiology, mechanisms, differential diagnoses, and prevention. Am J Kidney Dis. 2019;73:846–57.

Wang, T. J., Wu, C. K., Hu, C. C., Keller, J. J. & Lin, H. C. Increased Risk of co-morbid eye disease in patients with chronic renal failure: A population-based study. Ophthalmic Epidemiol. 19, 137–143 (2012).

Sabanayagam C, et al. Metabolic syndrome components and age-related cataract: The Singapore Malay Eye Study. Investig Ophthalmol Vis Sci. 2011;52: 2397–404.

Congdon NG, Friedman, DS, Lietman T. Important causes of visual impairment in the world today. 2003;290:2057–60.

Sun G, et al. The effect of hemodialysis on ocular changes in patients with the end-stage renal disease. Ren Fail. 2019;41:629–35.

Pék A, et al. Relationship between diabetes mellitus and cataract in Hungary. Int J Ophthalmol. 2020;13: 788–93.

Leske MC, Chylaek LT, Suh-Yuh Wu, et al. The lens opacities case-control study. Arch Ophthalmol. 1991;109:244–51.

Yu X, Lyu D, Dong X, He J, Yao K. Hypertension and risk of cataract: A meta-analysis. PLoS One. 2014;9: 1–17.

Bautista LE, Vera LM, Arenas IA, Gamarra G. Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-α) and essential hypertension. J Hum Hypertens. 2005;19:149–54.

Klein BEK, Klein R, Lee KE, Knudtson MD, Tsai MY. Markers of inflammation, vascular endothelial dysfunction, and age-related cataract. Am J Ophthalmol. 2006;141:116–22.

Sun W, et al. Correlation between conjunctival and corneal calcification and cardiovascular calcification in patients undergoing maintenance hemodialysis. Hemodial Int. 2015;19:270–8.

Downloads

Published

2022-04-08

How to Cite

Widjaja, S. A., Ono, K., Hiratsuka, Y., Yustiarini, I., Widodo, W., & Murakami, A. (2022). Major Ocular Abnormalities Among Hemodialysis Patients in Indonesia. Acta Medica Indonesiana, 54(1), 52. Retrieved from https://www.actamedindones.org/index.php/ijim/article/view/1950

Issue

Vol. 54 No. 1 (2022): Acta Medica Indonesiana

Section

ORIGINAL ARTICLE

License

Copyright

The authors who publish in this journal agree to the following requirements:

  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a  Creative Commons Attribution 4.0 International License (CC BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work. (See The Effect of Open Access)

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.